Lixte Biotech Holdings (NASDAQ: LIXT) is advancing the frontiers of precision oncology, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects. By focusing […]

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is a rare earth and critical metals exploration company that’s focused on developing a portfolio of district-scale mining opportunities across the Americas. The company holds a diverse portfolio of projects throughout […]

Earth Science Tech (OTC: ETST) is consolidating on its identity as a leading healthcare holding company, implementing a strategy built on vertical integration across telemedicine, pharmaceuticals, and clinical services. The company’s transitioning from legacy operations highlights a distinct alignment with high-growth segments of the healthcare sector, particularly personalized medicine and digital care delivery (ibn.fm/9lMJg). At […]

As artificial intelligence and robotics transition from experimental innovation into real-world deployment, the economics of automation are undergoing a fundamental transformation. Nightfood Holdings Inc. (OTCQB: NGTF), acting through its subsidiary TechForce Robotics, is leveraging this evolution by advancing RaaSP, a platform that eliminates a major impediment to adoption: upfront capital expense (ibn.fm/bmrvL). Within the past […]

American Fusion (OTC: AMFN), an advanced energy platform company focused on the development and commercialization of fusion energy technologies has formally completed a corporate name and ticker symbol change that signals the company’s transition toward fusion energy development. The Texas-based company, formerly known as Renewal Fuels, Inc., began trading under its new identity and ticker […]

MindWave Innovations (NYSE American: APUS) is a digital asset and technology company providing institutional-grade treasury infrastructure for the digital asset economy. The company offers a secure and compliant gateway to digital assets through insured custody solutions, AI-enabled yield strategies, and transparent reporting systems. MindWave is focused on supporting corporations and institutional counterparties in holding, managing, and […]

HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company’s push to expand its role in next-generation cardiac monitoring. The announcement highlights HeartBeam’s growing focus on artificial intelligence (“AI”)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward […]

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver (CSE: CXC) (OTC: CXXMF), an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, recognizes that global demand and geopolitical factors are further boosting silver prices. To capitalize on this growth, the […]

For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques while the underlying physics of photon radiation remained largely unchanged. The core limitation persisted: photon beams pass through the body, leaving an exit dose of radiation in tissue beyond the tumor. The question oncologists repeatedly returned to was not whether this collateral […]

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing therapies for rare diseases and unmet medical needs, is featured in a detailed research report issued by Zacks Small-Cap Research. The March 12 report provides a comprehensive look at the company’s pipeline, financial positioning and upcoming clinical catalysts, underscoring the potential value proposition for investors […]